EXACT Therapeutics

📍 Oslo, Norway🗓 Founded 2012👥 16 employees💰 Last funded Dec 2024
Biotechnology Research🌐 exact-tx.com
Website LinkedIn
EXACT Therapeutics ("EXACT-Tx") is a clinical-stage biopharmaceutical company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Norway
2
Belgium
1
Investor activity2019–2024 · investors recorded per year
201912021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in EXACT Therapeutics?
EXACT Therapeutics has 3 investors on record on gritt.io and 2 late-stage investors.
When did EXACT Therapeutics last raise funding?
The most recent investment in EXACT Therapeutics recorded on gritt.io was in December 2024.
When was EXACT Therapeutics founded?
EXACT Therapeutics was founded in 2012.
What industry is EXACT Therapeutics in?
EXACT Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EXACT Therapeutics based?
EXACT Therapeutics is headquartered in Oslo, Norway.